Journal of Vascular Surgery
Volume 48, Issue 4 , Pages 897-904.e1 , October 2008

Nutrition impacts the prevalence of peripheral arterial disease in the United States

Presented at the Twenty-second Annual Western Vascular Society Meeting, Kona, Hawaii, Sept 8-11, 2007.

  • John S. Lane, MD

      Affiliations

    • Department of Surgery, University of California, Irvine, Orange, Calif
    • Division of Vascular Surgery, University of California, Irvine, Orange, Calif
    • Center for Health Policy Research, University of California, Irvine, Orange, Calif
    • Corresponding Author InformationCorrespondence: John S. Lane, MD, UC Irvine Division of Vascular Surgery, 333 City Blvd W, Ste 700, Room 712, Orange, CA 92868
    • ,
  • Cheryl P. Magno, MPH

      Affiliations

    • Department of Surgery, University of California, Irvine, Orange, Calif
    • Center for Health Policy Research, University of California, Irvine, Orange, Calif
    • ,
  • Karen T. Lane, MD

      Affiliations

    • Department of Surgery, University of California, Irvine, Orange, Calif
    • Center for Health Policy Research, University of California, Irvine, Orange, Calif
    • ,
  • Tyler Chan, BS

      Affiliations

    • Center for Health Policy Research, University of California, Irvine, Orange, Calif
    • ,
  • David B. Hoyt, MD

      Affiliations

    • Department of Surgery, University of California, Irvine, Orange, Calif
    • ,
  • Sheldon Greenfield, MD

      Affiliations

    • Center for Health Policy Research, University of California, Irvine, Orange, Calif

Received 22 February 2008 ,Accepted 6 May 2008.

References 

  1. Hankey GJ, Norman PE, Eikelboom JW. Medical treatment of peripheral arterial disease. JAMA. 2006;295:547–553
  2. McDermott MM, Mehta S, Ahn H, Greenland P. Atherosclerotic risk factors are less intensively treated in patients with peripheral arterial disease than in patients with coronary artery disease. J Gen Intern Med. 1997;12:209–215
  3. World Health Organization. Part 2: Recommendations for Prevention of Cardiovascular Disease. In: Prevention of Cardiovascular Disease: Guidelines for Assessment and Management for Cardiovascular Risk. Geneva Switzerland: WHO Press; 2007;http://www.who.int/cardiovascular_diseases/guidelines/Full%20text.pdf
  4. Centers for Disease Control and Prevention (CDC), National Center for Health Statistics (NCHS), National Health and Nutrition Examination Survey Data (NHANES). Hyattsville, MD: US Department of Health and Human Services, Centers for Disease Control and Prevention; 1999-2004. http://www.cdc.gov/nchs/nhanes.htm.
  5. Sacks D, Bakal CW, Beatty PT, Becker GJ, Cardella JF, Raabe RD, et al. Position statement on the use of the ankle-brachial index in the evaluation of patients with peripheral vascular disease: a consensus statement developed by the standards division of the society of cardiovascular & interventional radiology. J Vasc Interv Radiol. 2002;13:353
  6. U.S. Department of Health and Human Services. U.S. Department of Agriculture. Dietary Guidelines for Americans. Rockville, MD: US Department of Health and Human Services; 2005;
  7. National Academy of Sciences, Institute of Medicine, Food and Nutrition Board. Dietary Reference Intakes (DRI): Recommended Intakes for Individuals. Washington, DC: National Academies Press; 2004;
  8. Karvetti RL, Knuts LR. Validity of the 24-hour dietary recall. J Am Diet Assoc. 1985;85:1437–1442
  9. Ross R. Atherosclerosis–an inflammatory disease. N Engl J Med. 1999;340:115–126
  10. Carrero JJ, Grimble RF. Does nutrition have a role in peripheral vascular disease?. Br J Nutr. 2006;95:217–229
  11. Mead A, Atkinson G, Albin D, Alphey D, Baic S, Boyd O, et al. Dietetic guidelines on food and nutrition in the secondary prevention of cardiovascular disease - evidence from systematic reviews of randomized controlled trials (second update, January 2006). J Hum Nutr Diet. 2006;19:401–419
  12. Spark JI, Robinson JM, Gallavin L, Gough MJ, Homer-Vanniasinkam S, Kester RC, et al. Patients with chronic critical limb ischaemia have reduced total antioxidant capacity and impaired nutritional status. Eur J Vasc Endovasc Surg. 2002;24:535–539
  13. Donnan PT, Thomson M, Fowkes FG, Prescott RJ, Housley E. Diet as a risk factor for peripheral arterial disease in the general population: the Edinburgh Artery Study. Am J Clin Nutr. 1993;57:917–921
  14. Langlois M, Duprez D, Delanghe J, De Buyzere M, Clement DL. Serum vitamin C concentration is low in peripheral arterial disease and is associated with inflammation and severity of atherosclerosis. Circulation. 2001;103:1863–1868
  15. Podmore ID, Griffiths HR, Herbert KE, Mistry N, Mistry P, Lunec J. Vitamin C exhibits pro-oxidant properties. Nature. 1998;392:559
  16. Klipstein-Grobusch K, den Breeijen JH, Grobbee DE, Boeing H, Hofman A, Witteman JC. Dietary antioxidants and peripheral arterial disease: the Rotterdam Study. Am J Epidemiol. 2001;154:145–149
  17. Lonn E, Bosch J, Yusuf S, Sheridan P, Pogue J, Arnold JM, et al. Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial. JAMA. 2005;293:1338–1347
  18. Kuan YM, Dear AE, Grigg MJ. Homocysteine: an aetiological contributor to peripheral vascular arterial disease. ANZ J Surg. 2002;72:668–671
  19. Ciccarone E, Di Castelnuovo A, Assanelli D, Archetti S, Ruggeri G, Salcuni N, et al. Homocysteine levels are associated with the severity of peripheral arterial disease in type 2 diabetic patients. J Thromb Haemost. 2003;1:2540–2547
  20. van den Berg M, Franken DG, Boers GH, Blom HJ, Jakobs C, Stehouwer CD, et al. Combined vitamin B6 plus folic acid therapy in young patients with arteriosclerosis and hyperhomocysteinemia. J Vasc Surg. 1994;20:933–940
  21. Wilmink AB, Welch AA, Quick CR, Burns PJ, Hubbard CS, Bradbury AW, et al. Dietary folate and vitamin B6 are independent predictors of peripheral arterial occlusive disease. J Vasc Surg. 2004;39:513–516
  22. Merchant AT, Hu FB, Spiegelman D, Willett WC, Rimm EB, Ascherio A. The use of B vitamin supplements and peripheral arterial disease risk in men are inversely related. J Nutr. 2003;133:2863–2867
  23. Lonn E, Yusuf S, Arnold MJ, Sheridan P, Pogue J, Micks M, et al. Homocysteine lowering with folic acid and B vitamins in vascular disease. N Engl J Med. 2006;354:1567–1577
  24. Bønaa KH, Njølstad I, Ueland PM, Schirmer H, Tverdal A, Steigen T, et al. Homocysteine lowering and cardiovascular events after acute myocardial infarction. N Engl J Med. 2006;354:1578–1588
  25. Merchant AT, Hu FB, Spiegelman D, Willett WC, Rimm EB, Ascherio A. Dietary fiber reduces peripheral arterial disease risk in men. J Nutr. 2003;133:3658–3663
  26. King DE, Egan BM, Geesey ME. Relation of dietary fat and fiber to elevation of C-reactive protein. Am J Cardiol. 2003;92:1335–1339
  27. Calder PC. n-3 Fatty acids and cardiovascular disease: evidence explained and mechanisms explored. Clin Sci (Lond). 2004;107:1–11
  28. Thies F, Garry JM, Yaqoob P, Rerkasem K, Williams J, Shearman CP, et al. Association of n-3 polyunsaturated fatty acids with stability of atherosclerotic plaques: a randomised controlled trial. Lancet. 2003;361:477–485
  29. Mozaffarian D, Rimm EB. Fish intake, contaminants, and human health: evaluating the risks and the benefits. JAMA. 2006;296:1885–1899
  30. Stark AH, Madar Z. Olive oil as a functional food: epidemiology and nutritional approaches. Nutr Rev. 2002;60:170–176
  31. Carrero JJ, Lopez-Huertas E, Salmeron LM, Baro L, Ros E. Daily supplementation with (n-3) PUFAs, oleic acid, folic acid, and vitamins B-6 and E increases pain-free walking distance and improves risk factors in men with peripheral vascular disease. J Nutr. 2005;135:1393–1399

 Competition of interest: none.

 Additional material for this article may be found online at www.jvascsurg.org.

PII: S0741-5214(08)00732-5

doi: 10.1016/j.jvs.2008.05.014

Journal of Vascular Surgery
Volume 48, Issue 4 , Pages 897-904.e1 , October 2008

Article Tools